Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia.

Chopra, Jagrati; Hiew, Hwai J; Cumpstey, Andrew; Cagampang, Felino; Jenner, Matthew W; Dushianthan, Ahilanandan

Chopra, Jagrati; Hiew, Hwai J; Cumpstey, Andrew; Cagampang, Felino; Jenner, Matthew W; Dushianthan, Ahilanandan.

Affiliation

Chopra J; General Intensive Care Unit, University of Southampton, Southampton, UK.
Hiew HJ; Haematology Department, University of Southampton, Southampton, UK.
Cumpstey A; General Intensive Care Unit, University of Southampton, Southampton, UK.
Cagampang F; School of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.
Jenner MW; Haematology Department, University of Southampton, Southampton, UK.
Dushianthan A; General Intensive Care Unit, University of Southampton, Southampton, UK.

Br J Haematol ; 190(4): e195-e198, 2020 08.

Article de En | MEDLINE | ID: mdl-32593202

Sujet(s)
Mots clés

COVID-19; chronic myelomonocytic leukaemia; respiratory failure

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Insuffisance respiratoire / Leucémie myélomonocytaire chronique / SARS-CoV-2 / Traitements médicamenteux de la COVID-19 / Hydroxy-urée Limites: Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 2020 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google